Mr. Palumbo to join Dario's third quarter 2026 earnings call to share the Board's view on the convergence of consumer and payer-led healthcare and chronic care managementNEW YORK, Nov. 4, 2026 /PRNewswire/ --
Company to host conference call and webcast at 8:30 a.m. Eastern TimeNEW YORK, Nov. 2, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leading artificial intelligence
Contract extension follows benefits realized from Dario's cardiometabolic program and strong employee demand for perimenopause supportNearly 45% of Dario's current book of business is women over age 40 who could
A component study of the independent review by Aon found $5,077 in annual savings and 23.5% fewer inpatient discharges per Dario user with type 2 diabetes versus matched non-usersEvaluation of 17 studies estimates $3.8
Agreement secured through channel partner Amwell significantly expands Dario's reach through its channel distribution strategyProgram for Dario's cardiometabolic suite and provider-backed care expected to launch
Second quarter 2026 revenue was $5.2 million, reflecting the Company's strategic decision to discontinue certain pharmaceutical-related businessGross margin increased to 62%, compared to 57% in the first quarter of
New programs, expected to begin revenue contribution Q4 2026, extend Dario's integrated healthcare platform into two high-impact clinical categories while advancing execution of the Company's provider-backed
Company to host conference call and webcast at 8:30 a.m. Eastern TimeNEW YORK, Aug. 3, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leading artificial intelligence
First commercial offering from Dario's collaboration with Beluga Health adds licensed provider evaluation, prescribing and ongoing clinical oversight directly inside Dario's chronic care platform Commercial
The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investorNEW YORK, July 22, 2026 /PRNewswire/ -- DarioHealth
Contract award for over 100,000 eligible employees marks Dario's fifth Fortune 50 client, further reflecting growing demand among large employers for integrated, outcomes-driven chronic condition managementProgram
DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recurring revenue growth for DarioDario IQ's AI-driven personalization increases member engagement by 40% and improves
Agreement representative of Dario's channel-led growth strategy to bring cardiometabolic digital health solution at scale to self-insured employers seeking measurable reductions in cardiometabolic risk and total
Third health plan customer to expand beyond initial deployment, reinforcing Dario's land-and-expand strategy and creating significant opportunity to grow revenue within existing customer baseNEW YORK, July 2, 2026
O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight and payer operations expected to support Dario's continued expansion with health plans, employers and
